Targeted Therapy for Myelodysplastic Syndromes

Targeted therapy uses drugs to target specific changes in cancer cells that help them grow, divide, and spread. Targeted therapy drugs are designed to be more precise. They fight cancer cells while causing less harm to other cells in the body.  

This is the latest type of targeted therapy that is available to treat myelodysplastic syndromes.

Please note: The side effects listed here do not represent a comprehensive list. It's important to discuss all potential side effects of a drug with your health care team. Be sure to tell your health care team about any side effects you do have.

All Available Treatments

Intravenous =
Pill =

Treatment Type

Tyrosine Kinase Inhibitor

Drug Name
Gleevec® (imatinib mesylate) (Pill)
Potential Side Effects
Bleeding Diarrhea Fatigue/weakness Joint pain/stiffness Low blood counts Muscle cramps Nausea/vomiting Skin/nail changes Swelling Weight/appetite changes
Important Things to Know
  • This drug may be an option for MDS that tests positive for PDGFR.
  • Low blood counts are a potential side effect that may put you at risk for anemia, infection, or bleeding.